News

Pharmabiz5h
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...
Pharmabiz7h
Alto Neuroscience enters into an asset purchase agreement with Chase Therapeutics Corporation
Alto Neuroscience enters into an asset purchase agreement with Chase Therapeutics Corporation: Mountain View, Califfornia Thursday, June 5, 2025, 16:00 Hrs [IST] Alto Neuroscience ...
Pharmabiz8h
MarkHerz inks MoU with Technical University of Munich Hospital to develop cardiovascular and diabetes-targeted AAV gene therapies
MarkHerz inks MoU with Technical University of Munich Hospital to develop cardiovascular and diabetes-targeted AAV gene therapies: Munich Thursday, June 5, 2025, 15:00 Hrs [IST] M ...
Pharmabiz15h
India revises list of stakeholders in anti-dumping probe on NBR from China, EU, Korea & Russia
India revises list of stakeholders in anti-dumping probe on NBR from China, EU, Korea & Russia: Shardul Nautiyal, Mumbai Thursday, June 5, 2025, 08:00 Hrs [IST] In a significant d ...
Pharmabiz8h
Alvotech and Dr. Reddy’s collaborate to co-develop oncology biosimilar candidate
Alvotech and Dr. Reddy’s collaborate to co-develop oncology biosimilar candidate: Our Bureau, Bengaluru Thursday, June 5, 2025, 14:30 Hrs [IST] Alvotech a global biotech company ...
Pharmabiz9h
QuidelOrtho announces strategy to speed up growth in molecular diagnostics
QuidelOrtho announces strategy to speed up growth in molecular diagnostics: San Diego Thursday, June 5, 2025, 14:00 Hrs [IST] QuidelOrtho Corporation, a global provider of innovat ...
Pharmabiz10h
Bayer blockbuster Nubeqa receives US FDA approval for patients with advanced prostate cancer
Bayer blockbuster Nubeqa receives US FDA approval for patients with advanced prostate cancer: Berlin Thursday, June 5, 2025, 13:00 Hrs [IST] Bayer announced that the US Food and D ...
Pharmabiz11h
Johnson & Johnson’s Akeega from AMPLITUDE study shows improved efficacy in patients with HRR-mutated mHSPC
Johnson & Johnson’s Akeega from AMPLITUDE study shows improved efficacy in patients with HRR-mutated mHSPC: Beerse, Belgium Thursday, June 5, 2025, 12:00 Hrs [IST] Johnson & Joh ...
Pharmabiz13h
Molecular Health & Axxam ink partnership to bolster discovery of innovative targets indrug development
Molecular Health & Axxam ink partnership to bolster discovery of innovative targets indrug development: Milan, Italy Thursday, June 5, 2025, 10:00 Hrs [IST] Axxam S.p.A., a premie ...
Pharmabiz14h
European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy
European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...
Pharmabiz12h
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease: Paris Thursday, June 5, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ( ...
Pharmabiz14h
India reports 4,302 active Covid-19 cases
With the Covid-19 virus once again emerging as a health concern, India has reported 4,302 active cases, with an increase of 864 cases in the past 24 hours as of June 4, 2025. Most cases are mild and ...